SIGNAL TRANSDUCTION BY CALCINEURIN IN T LYMPHOCYTES
T 淋巴细胞中钙调磷酸酶的信号转导
基本信息
- 批准号:6386694
- 负责人:
- 金额:$ 0.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-05-01 至 2001-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Adapted from the investigator's abstract) The major goal of
this proposal is to gain a molecular understanding of the mechanism of
signal transduction by calcineurin during activation of T lymphocytes. The
investigator has identified calcineurin as an important enzyme in the T cell
receptor (TCR)-mediated signal transduction pathway leading to interleukin-2
(IL-2) production and as a common target for the immunosuppressive drugs
cyclosporin A and FK506. Calcineurin is known to modulate the activities of
at least three distinct classes of transcription factor including NF-AT,
NF-kB and AP-1. However, many of the signaling molecules involved in the
activation of NF-kB and AP-1 by calcineurin are not known. Calcineurin
exists in multiple isoforms; it has been assumed that the a isoform of
calcineurin mediates TCR signaling. Recently, calcineurin a was knocked out
in mice, but no defect in the TCR-mediated IL-2 production was observed. In
his preliminary studies, he has found that another isoform, calcineurin b,
is more abundant than calcineurin a in T cells, suggesting that calcineurin
b may play a dominant role in TCR signaling. Using FK506-resistant
calcineurin mutants, he proposes to assess whether calcineurin b is
sufficient to mediate TCR signaling. He will apply the yeast two-hybrid
system to identify the substrates and associated proteins for calcineurin b
to uncover signaling molecules involved in the activation of NF-kB and AP-1
by calcineurin. Alternatively, he will also employ catalytically inactive
calcineurin mutants to identify calcineurin substrates from Jurkat cell
extracts in vitro. Using partial cDNA sequences obtained from the yeast
two-hybrid screen or oligopeptide sequences obtained from in vitro binding,
the full length cDNA encoding putative calcineurin substrates and associated
proteins will be cloned and further characterized in the context of TCR
signaling. The identification of new signaling molecules through these
studies will not only shed light on the molecular mechanism of TR signal
transduction, but will also offer new targets for designing more specific
and less toxic immunosuppressants.
描述:(改编自研究者摘要)
这个提议是为了从分子水平上了解
T淋巴细胞活化过程中钙调磷酸酶信号转导。 的
研究者已经确定钙调神经磷酸酶是T细胞中的一种重要酶
受体(TCR)介导的信号转导途径导致白细胞介素-2
(IL-2)的产生和作为免疫抑制药物的共同靶点
环孢菌素A和FK 506。 已知钙调神经磷酸酶调节
至少三类不同的转录因子,包括NF-AT,
NF-κ B和AP-1。 然而,许多参与细胞凋亡的信号分子,
钙调磷酸酶对NF-κ B和AP-1的激活作用尚不清楚。 钙调
存在于多种亚型中;已经假定,
钙调磷酸酶介导TCR信号传导。 最近,钙调神经磷酸酶a被敲除,
但未观察到TCR介导的IL-2产生缺陷。 在
他的初步研究发现,另一种亚型,钙调神经磷酸酶B,
在T细胞中比钙调神经磷酸酶a更丰富,这表明钙调神经磷酸酶
B可能在TCR信号转导中起主导作用。 使用FK 506抗性
钙调神经磷酸酶突变体,他建议评估钙调神经磷酸酶B是否
足以介导TCR信号传导。 他将应用酵母双杂交技术
鉴定钙调磷酸酶B的底物和相关蛋白的系统
揭示参与NF-κ B和AP-1激活的信号分子
钙调磷酸酶 或者,他还将使用催化惰性的
从Jurkat细胞鉴定钙调磷酸酶底物的钙调磷酸酶突变体
体外提取物。 使用从酵母中获得的部分cDNA序列,
双杂交筛选或从体外结合获得的寡肽序列,
全长cDNA编码推定的钙调磷酸酶底物和相关的
蛋白质将被克隆并在TCR的背景下进一步表征
发信号。 通过这些新的信号分子的鉴定
研究不仅将揭示TR信号的分子机制,
转导,但也将提供新的目标,设计更具体的
和毒性更低的免疫抑制剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jun O. Liu其他文献
Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production.
沙利度胺与 α1-酸性糖蛋白的结合可能参与其抑制肿瘤坏死因子 α 的产生。
- DOI:
10.1073/pnas.93.15.7552 - 发表时间:
1996 - 期刊:
- 影响因子:11.1
- 作者:
B. Turk;Hongsi Jiang;Jun O. Liu - 通讯作者:
Jun O. Liu
Phase of the Cell Cycle 1 IL-2-Dependent T Cell Proliferation at the G Immunosuppressant, Inhibits Sanglifehrin A, a Novel Cyclophilin-Binding
细胞周期 1 阶段 IL-2 依赖性 T 细胞在 G 处增殖 免疫抑制剂抑制 Sanglifehrin A(一种新型亲环蛋白结合)
- DOI:
- 发表时间:
2001 - 期刊:
- 影响因子:0
- 作者:
Ling;Jun O. Liu - 通讯作者:
Jun O. Liu
suppresses the oncogenic activity of YAP YAP complex - Genetic and pharmacological disruption of the TEAD
抑制 YAP YAP 复合物的致癌活性 - TEAD 的遗传和药理学破坏
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Y. Liu;Bo Huang;J. Shim;Qian Chen;Se;Robert A. Anders;Jun O. Liu;Duojia Pan - 通讯作者:
Duojia Pan
Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
TNP-470 和卵黄素在内皮细胞中选择性抑制氨基末端甲硫氨酸加工。
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:0
- 作者:
Benjamin E. Turk;Eric C. Griffith;Susan M. Wolf;Klaus Biemann;Yie;Jun O. Liu - 通讯作者:
Jun O. Liu
Girolline is a sequence context-selective modulator of eIF5A activity
吉罗啉是一种 eIF5A 活性的序列上下文选择性调节剂
- DOI:
10.1038/s41467-024-54838-2 - 发表时间:
2025-01-10 - 期刊:
- 影响因子:15.700
- 作者:
Tilman Schneider-Poetsch;Yongjun Dang;Wakana Iwasaki;Mayumi Arata;Yuichi Shichino;Ali Al Mourabit;Celine Moriou;Daniel Romo;Jun O. Liu;Takuhiro Ito;Shintaro Iwasaki;Minoru Yoshida - 通讯作者:
Minoru Yoshida
Jun O. Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jun O. Liu', 18)}}的其他基金
Characterization of A Novel Proteasome Inhibitor
新型蛋白酶体抑制剂的表征
- 批准号:
10597711 - 财政年份:2022
- 资助金额:
$ 0.34万 - 项目类别:
Targeting Glucose Transporters Using Rapafucins
使用雷帕夫星靶向葡萄糖转运蛋白
- 批准号:
10335197 - 财政年份:2020
- 资助金额:
$ 0.34万 - 项目类别:
Targeting Glucose Transporters Using Rapafucins
使用雷帕夫星靶向葡萄糖转运蛋白
- 批准号:
10557907 - 财政年份:2020
- 资助金额:
$ 0.34万 - 项目类别:
Studies of the Antifungal Drug Itraconazole As A Novel Inhibitor of Angiogenesis
抗真菌药物伊曲康唑作为新型血管生成抑制剂的研究
- 批准号:
8817767 - 财政年份:2015
- 资助金额:
$ 0.34万 - 项目类别:
Generation and Proteome-Wide Screening of Hybrid Combinatorial Libraries
混合组合文库的生成和全蛋白质组筛选
- 批准号:
8520275 - 财政年份:2010
- 资助金额:
$ 0.34万 - 项目类别:
Generation and Proteome-Wide Screening of Hybrid Combinatorial Libraries
混合组合文库的生成和全蛋白质组筛选
- 批准号:
8323364 - 财政年份:2010
- 资助金额:
$ 0.34万 - 项目类别:
Generation and Proteome-Wide Screening of Hybrid Combinatorial Libraries
混合组合文库的生成和全蛋白质组筛选
- 批准号:
8151102 - 财政年份:2010
- 资助金额:
$ 0.34万 - 项目类别:
Generation and Proteome-Wide Screening of Hybrid Combinatorial Libraries
混合组合文库的生成和全蛋白质组筛选
- 批准号:
7979320 - 财政年份:2010
- 资助金额:
$ 0.34万 - 项目类别:
Generation and Proteome-Wide Screening of Hybrid Combinatorial Libraries
混合组合文库的生成和全蛋白质组筛选
- 批准号:
8705479 - 财政年份:2010
- 资助金额:
$ 0.34万 - 项目类别:
Discovery and Investigation of Novel Angiogenesis Inhibitors Among Existing Drugs
现有药物中新型血管生成抑制剂的发现和研究
- 批准号:
7351352 - 财政年份:2008
- 资助金额:
$ 0.34万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 0.34万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 0.34万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 0.34万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 0.34万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 0.34万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 0.34万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 0.34万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 0.34万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 0.34万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 0.34万 - 项目类别:
Discovery Grants Program - Individual